Introduction
Intestinal tissues primary serve as a site to digest and absorb nutrients, but they also simultaneously comprise a unique immune system. The intestinal immune system acts as the first line of defense against pathogens 1) . Additionally, the intestinal immune system is important to prevent unnecessary inflammatory responses and hypersensitivity to harmless or beneficial materials 2) . To achieve these opposite but harmonized immunologic functions, the in- .
Through a physiological function of intestine, they con- . Indeed, nutrient deficiencies often are coincident with the impaired intestinal immunity 14, 15) .
Vitamins are organic compounds that need to be supplied receptor CCR9 18, 19) , and the differentiation and activation of T cells 20) , innate lymphoid cells 21) , and mast cells 22) . Another example is vitamin B6, which is required for the metabolic pathway of sphingosine 1-phosphate, a lipid mediator that regulates cell trafficking 23) . Thus, disruption of vitamin B6
function results in aberrant T-cell differentiation and cell trafficking in both systemic and intestinal compartments [24] [25] [26] .
Nucleotides, especially adenosine 5'-triphosphate (ATP), emerge as key molecules in the regulation of many physiological and pathological processes. Generally, ATP is generated during glycolysis and the tricarboxylic acid cycle in the intracellular compartment and acts as an energy source. However, ATP is occasionally released into the extracellular compartment passively following cellular stress or cell death, inducing the inflammatory responses via signaling through membrane-bound purinergic P2 receptors 27) . P2 receptors can be divided into G-proteincoupled P2Y receptors, and nucleotide-gated ion channel P2X receptors 28) . Different types of P2X and P2Y receptors are expressed on various immune and non-immune cells, leading to the diverse involvement in the several inflammatory responses.
In this review, we focus on vitamin B9 and ATP in the control of immunologic balance between physiologic and pathologic conditions of the intestine.
Homeostatic function of vitamin B9 in the maintenance of immunological homeostasis in the intestine
Vitamin B9 (also known as folate and folic acid) is a water-soluble vitamin abundantly present in the leafy greens such as spinach, broccoli, and parsley (Fig. 1) . Like other vitamins, vitamin B9 is not synthesized in mammals, and thus mammalian species must obtain vitamin B9
exogenously. Vitamin B9 is essential for the synthesis, replication, and repair of nucleotides for DNA and RNA and is thus required for cell proliferation and survival 29) . As an immunological function of vitamin B9, it was known that vitamin B9 deficiency reduced the proliferative responses of lymphocytes and natural killer cell activity 30, 31) .
It was reported that the vitamin B9 receptor folate receptor . Due to the regulatory functions of Treg in the maintenance of immunological homeostasis, the reduction of Treg cells in the vitamin B9-deficient condition was accompanied with the high susceptibility to intestinal inflammation ( Fig. 1) 
(FR4) is specifically expressed on Treg
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. These findings suggest that dietary vitamin B9 is a critical factor to keep the appropriate numbers of Treg cells and consequent maintenance of immunological homeostasis in the intestine. It has been proposed that, in addition to diets, commensal bacteria is able to produce vitamin B9 and its production activity was differ among commensal bacteria 35) . Therefore, composition of commensal bacteria is likely to be another determinant of vitamin B9/Treg-mediated maintenance of immunological homeostasis in the gut.
Mast cells mediate the development of intestinal inflammation through the recognition of extracellular ATP by P2X7 receptors
ATP is an energy source in the intracellular compartment, but is occasionally released into the extracellular compartments. Extracellular ATP acts as a danger signal by recruiting and activating immune cells 27, 28) . Major sources of extracellular ATP are damaged tissues, and dead and activated cells including inflammatory cells (Fig. 2) . Extracellular ATP is recognized by P2 receptors including several P2X receptors and P2Y receptors 28) .
Among them, P2X7 receptors are involved mainly in the induction of inflammatory responses. Indeed, high levels of P2X7 receptor expression was observed in the intestinal mucosa of Crohn's disease patients 36) , and treatment with P2X7 inhibitors (e.g., A-740003, Brilliant Blue G, and KN-62) ameliorated experimental colitis 37) . These findings collectively implicate that extracellular ATP-P2X7 pathway is a novel therapeutic target in the treatment of intestinal receptors in different tissues 27) , P2X7 receptor expression was predominantly observed on mast cells in the colon 36) .
Extracellular ATP-mediated mast cell activation through P2X7 receptors leads to the production of inflammatory chemokines (e.g., CCL2, CCL4, CCL7, CXCL1, and CXCL2), cytokines (IL-1β, IL-6, and TNFα), and mediators (histamines and leukotriene) (Fig. 2) . Therefore, treatment with 1F11 mAb prevents these pathways and consequently inhibits the development of intestinal inflammation 36) . We recently found that, unlike colonic mast cells, skin mast cells barely expressed P2X7 receptors and skin fibroblasts were involved in the down-regulation of P2X7 receptors on mast cells 22) . Thus, tissue environments determine P2X7 expression on mast cells, which is a critical factor in the development of local inflammation.
Conclusion
Immunological These findings provide new strategies in the development of pharmacological agents and/or functional foods for the maintenance of a healthy immune condition in the intestine.
